| Product Code: ETC7746758 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Prophylactic Vaccines Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Japan Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Japan Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Japan Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Japan Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Japan Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Japan Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Japan Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Japan |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing prevalence of infectious diseases in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for vaccines |
4.3.2 High cost associated with vaccine development and production in Japan |
5 Japan Prophylactic Vaccines Market Trends |
6 Japan Prophylactic Vaccines Market, By Types |
6.1 Japan Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Japan Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Japan Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Japan Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Japan Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Japan Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Japan Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Japan Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Japan Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Japan Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Japan Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Japan Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Japan Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Japan Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Japan Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Japan Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Japan Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Japan Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Japan Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Japan Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Japan Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Japan Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Japan Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Japan Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Japan Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Japan Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Japan Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Japan Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Japan Prophylactic Vaccines Market Export to Major Countries |
7.2 Japan Prophylactic Vaccines Market Imports from Major Countries |
8 Japan Prophylactic Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates for key target populations |
8.2 Number of new vaccines introduced in the market |
8.3 Research and development investment in vaccine technologies and innovations |
9 Japan Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Japan Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Japan Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Japan Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Japan Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Japan Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Japan Prophylactic Vaccines Market - Competitive Landscape |
10.1 Japan Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Japan Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here